NASDAQ:ADMS - Adamas Pharmaceuticals, Inc.
$11.11
 $0.12
+1.09%
4:20PM EDT
2019-02-22
Adamas Pharmaceuticals, Inc. is a pharmaceutical company. The Company is engaged in developing medicines to manage the daily lives of those affected by chronic neurologic disorders. It offers a platform based on an understanding of time dependent biologic effects of disease activity and drug response to achieve relief without tolerability issues. It has developed a portfolio of chrono-synchronous therapies to address chronic neurologic disorders. Its first product candidate is ADS-5102, a chrono-synchronous amantadine therapy, for the treatment of levodopa-induced dyskinesia (LID) in patients with Parkinson's disease (PD). It has completed Phase II proof-of-concept study of ADS-5102 in these patients. Its Phase III clinical program included three placebo-controlled trials: EASED, EASE LID and EASE LID 3. Its second product candidate is ADS-4101, an extended-release version of single-agent compound for the treatment of epilepsy (partial onset seizures). Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  ADMS     avg for
industry  
  avg for
sector  
42 stocks weight:  35. 29   0. 00   0. 00  
42 stocks rank:  3. 12 K 2. 00 K 1. 08 K
# analyst opinions:  10. 00   14. 68   14. 18  
mean recommendation:  2. 00   1. 96   1. 94  

quick ratio:  8. 57   5. 17   1. 75  
current ratio:  8. 95   5. 48   2. 10  

target price low:  7. 50   90. 05   118. 16  
target price avg:  11. 00   115. 98   142. 03  
target price high:  11. 52   141. 44   162. 86  
1-yr high:  32. 67   124. 28   143. 16  
last close:  11. 11   102. 75   129. 63  
50-day avg:  9. 08   98. 90   122. 76  
200-day avg:  18. 61   100. 04   123. 17  
1-yr low:  7. 75   78. 22   100. 14  
volume:  484. 35 K 2. 36 M 4. 94 M
50-day avg volume:  521. 82 K 3. 14 M 4. 85 M
200-day avg volume:  577. 32 K 3. 12 M 4. 26 M

1-day return:  1. 09 % 1. 74 % 0. 96 %
this week return:  5. 51 % -0. 72 % -0. 25 %
12-wk return:  8. 50 % 1. 23 % -0. 75 %
52-wk return:  -58. 99 % -2. 03 % 16. 23 %

enterprise value (EV):  195. 83 M 54. 82 B 107. 48 B
market cap:  303. 69 M 47. 12 B 97. 54 B
EBITDA:  -117. 23 M 4. 72 B 7. 18 B
enterprise multiple (EV/EBITDA):  -1. 67   9. 03   16. 84  
enterprise/revenue (EV/R):  9. 19   31. 24   24. 21  
total revenue:  21. 30 M 11. 05 B 40. 03 B
total debt:  115. 35 M 13. 41 B 16. 70 B
debt/equity:  100. 84   41. 61   80. 63  
net income (common):  -131. 47 M 2. 34 B 3. 61 B

shares outstanding:  27. 34 M 594. 48 M 1. 22 B
shares:  18. 00 M 592. 96 M 1. 15 B
shares short:  6. 41 M 10. 54 M 11. 92 M
shares short prior month:  6. 43 M 11. 90 M 11. 87 M
short ratio:  14. 74   4. 86   3. 18  
short % of float:  29. 69 % 6. 23 % 2. 78 %
total cash/share:  7. 74   11. 99   10. 04  
total cash:  211. 47 M 7. 30 B 7. 05 B
free cash flow:  -71. 75 M 176. 15 M 2. 43 B
operating cash flow:  -105. 44 M 277. 94 M 3. 06 B

book value:  4. 18   15. 06   28. 80  
price/book:  2. 65   -0. 58   -2. 51  
gross profits:  554. 00 K 8. 33 B 19. 31 B
operating margins:  -557. 02 % -466. 96 % -635. 17 %
EBITDA margins:  0. 00 % 13. 54 % 22. 51 %
profit margins:  0. 00 % 6. 67 % 10. 02 %
gross margins:  98. 99 % 48. 21 % 54. 28 %

1-yr max volatility:  -29. 94 % --- ---
1-yr mean volatility:  -0. 27 % 0. 01 % 0. 07 %

1-yr EPS:  -5. 10   3. 08   4. 11  
forward EPS:  -4. 38   4. 75   7. 18  
P/E:  -2. 18   15. 54   29. 27  
forward P/E:  -2. 51   -20. 90   3. 33  
PE/G:  -0. 00   1. 33   6. 07  
growth:  1061200. 00 % 755. 42 % 114. 65 %
earnings high:  -1. 16   1. 33   1. 68  
earnings avg:  -1. 34   0. 97   1. 54  
earnings low:  -1. 54   0. 70   1. 41  
revenue high:  13. 30 M 2. 81 B 11. 37 B
revenue avg:  13. 26 M 2. 70 B 11. 06 B
revenue low:  12. 90 M 2. 61 B 10. 84 B
return on assets:  -37. 62 % -3. 63 % 3. 73 %
return on equity:  -131. 29 % 102. 34 % 26. 90 %
revenue growth:  1061200. 00 % 717. 29 % 107. 00 %
revenue/share:  0. 82   14. 67   60. 08  

beta (1yr vs S&P500):  1. 01   1. 22   0. 94  
sharpe (1yr):  -1. 10   0. 14   1. 05  

held % insiders:  2. 49 % 6. 40 % 3. 16 %
held % institutions:  113. 30 % 79. 62 % 70. 81 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-02-22 : ADMS
.        + 0 =             0 :: INITIAL WEIGHT
.   + 70.744 =        70.744 :: inverse volume-to-price addition
.  + 123.364 =       194.108 :: spline projection addition
.  - 152.794 =        41.314 :: poor performance penalty
.    x 0.633 =        26.149 :: one-year gains+dividend factor
.    x 8.247 =       215.654 :: 13 weeks' performance factor
.    x 1.478 =       318.725 :: industry recommendation factor
.    x 2.233 =       711.686 :: symbol recommendation factor
.    x 1.294 =       921.139 :: EV/R factor
.    x 0.996 =       917.674 :: return on assets factor
.    x 0.987 =       905.625 :: return on equity factor
.    x 6.713 =      6079.719 :: revenue growth factor
.    x 2.369 =     14400.784 :: current ratio factor
.    x 1.064 =       15322.7 :: quick ratio factor
.    x 1.033 =     15833.937 :: short ratio factor
.    x 2.027 =     32088.221 :: price-to-book factor
.    x 1.193 =      38280.02 :: debt-to-equity factor
.    x 1.201 =     45978.843 :: 5-day avg > 50-day avg
.    x 2.141 =     98438.208 :: P/E weight
.    x 2.209 =    217445.976 :: PE/G factor
.    x 1.761 =    382921.252 :: beta factor
.    x 0.823 =    314977.571 :: sharpe factor
.    x 0.943 =    297022.952 :: target low factor
.    x 0.982 =    291784.484 :: target mean factor
.    x 1.019 =    297408.991 :: target high factor
.    x 1.012 =     301070.68 :: industry 12-weeks return
.    x 0.958 =    288463.417 :: "drift" penalty 1 days ago
.    x 0.967 =    278996.831 :: "drift" penalty 3 days ago
.    x 0.958 =    267318.256 :: "drift" penalty 4 days ago
.    x 0.999 =    267033.727 :: overall "drift" factor
.    x 0.999 =    266699.263 :: largest single-day jump factor
.    x 0.165 =     43937.276 :: low price factor
.      x 1.0 =     43932.722 :: factor hist industry gain for week 07
.   cubeRoot =        35.285 :: reduced for readability
.                     35.285 :: FINAL WEIGHT for NASDAQ:ADMS


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org